FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011315878> ?p ?o ?g. }

• W3011315878 endingPage "1686" @default.
• W3011315878 startingPage "1678" @default.
• W3011315878 abstract "Objective Antisynthetase syndrome (AS)-related interstitial lung disease (ILD) has a poor prognosis. Intravenous cyclophosphamide (IV CYC) and rituximab (RTX) are the main treatments currently used for moderate to severe ILD. Here, we compare the efficacy of CYC followed by standard immunosuppressive treatment (IST) versus RTX in AS-related ILD. Methods This observational retrospective study was conducted between 2003 and 2016 in 3 tertiary care centers. All patients with AS-related ILD and treated with CYC or RTX with at least 6 months of follow-up were included. Pulmonary progression-free survival (PFS), defined according to the American Thoracic Society guidelines, was assessed at 6 months and 2 years. All severe adverse events (AE) were recorded. Results Sixty-two patients were included. Thirty-four patients received 2–12 monthly IV CYC pulses, followed by standard IST in 30 cases (88%). The RTX group included 28 patients. Following the initial Day 1 to Day 15 infusions, RTX was repeated every 6 months in 26 cases (93%) and 15 patients (54%) concomitantly received another IST. The median steroid dose was similar between both groups. Although RTX and CYC demonstrated similar PFS at 6 months (92% vs 85%, respectively), RTX was superior at 2 years (HR 0.263, 95% CI 0.094–0.732, P = 0.011). Interestingly, lower diffusing lung capacity for carbon monoxide (DLCO) at baseline was independently predictive of poor 2-year PFS [0.965 (0.936–0.995), P = 0.023]. Forced vital capacity and DLCO improved in both groups without significant differences. Serious AE were similar in both groups. Conclusion Despite similar PFS at 6 months, RTX was associated with a better 2-year PFS compared to CYC in patients with AS-related ILD." @default.
• W3011315878 created "2020-03-23" @default.
• W3011315878 creator A5000662815 @default.
• W3011315878 creator A5002364122 @default.
• W3011315878 creator A5008531719 @default.
• W3011315878 creator A5018486655 @default.
• W3011315878 creator A5027584008 @default.
• W3011315878 creator A5027640760 @default.
• W3011315878 creator A5034549468 @default.
• W3011315878 creator A5051029267 @default.
• W3011315878 creator A5065370227 @default.
• W3011315878 creator A5082395003 @default.
• W3011315878 creator A5084707615 @default.
• W3011315878 date "2020-03-15" @default.
• W3011315878 modified "2023-10-14" @default.
• W3011315878 title "Rituximab and Cyclophosphamide in Antisynthetase Syndrome–related Interstitial Lung Disease: An Observational Retrospective Study" @default.
• W3011315878 cites W1790191554 @default.
• W3011315878 cites W1914819555 @default.
• W3011315878 cites W1971734001 @default.
• W3011315878 cites W1974946256 @default.
• W3011315878 cites W1991855818 @default.
• W3011315878 cites W2000040082 @default.
• W3011315878 cites W2005047597 @default.
• W3011315878 cites W2036487008 @default.
• W3011315878 cites W2042169028 @default.
• W3011315878 cites W2042926190 @default.
• W3011315878 cites W2054130063 @default.
• W3011315878 cites W2063791291 @default.
• W3011315878 cites W2068014499 @default.
• W3011315878 cites W2071793391 @default.
• W3011315878 cites W2076417190 @default.
• W3011315878 cites W2098063632 @default.
• W3011315878 cites W2107051779 @default.
• W3011315878 cites W2110201345 @default.
• W3011315878 cites W2122161608 @default.
• W3011315878 cites W2125564484 @default.
• W3011315878 cites W2126188363 @default.
• W3011315878 cites W2126996887 @default.
• W3011315878 cites W2150734110 @default.
• W3011315878 cites W2158862125 @default.
• W3011315878 cites W2167383172 @default.
• W3011315878 cites W2168592878 @default.
• W3011315878 cites W2174731795 @default.
• W3011315878 cites W2321119904 @default.
• W3011315878 cites W2330547886 @default.
• W3011315878 cites W2333551703 @default.
• W3011315878 cites W2338714174 @default.
• W3011315878 cites W2344307926 @default.
• W3011315878 cites W2374913422 @default.
• W3011315878 cites W2576043950 @default.
• W3011315878 cites W2581749430 @default.
• W3011315878 cites W2594723614 @default.
• W3011315878 cites W2626588662 @default.
• W3011315878 cites W2794900939 @default.
• W3011315878 cites W2891506196 @default.
• W3011315878 doi "https://doi.org/10.3899/jrheum.190505" @default.
• W3011315878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32173654" @default.
• W3011315878 hasPublicationYear "2020" @default.
• W3011315878 type Work @default.
• W3011315878 sameAs 3011315878 @default.
• W3011315878 citedByCount "17" @default.
• W3011315878 countsByYear W30113158782021 @default.
• W3011315878 countsByYear W30113158782022 @default.
• W3011315878 countsByYear W30113158782023 @default.
• W3011315878 crossrefType "journal-article" @default.
• W3011315878 hasAuthorship W3011315878A5000662815 @default.
• W3011315878 hasAuthorship W3011315878A5002364122 @default.
• W3011315878 hasAuthorship W3011315878A5008531719 @default.
• W3011315878 hasAuthorship W3011315878A5018486655 @default.
• W3011315878 hasAuthorship W3011315878A5027584008 @default.
• W3011315878 hasAuthorship W3011315878A5027640760 @default.
• W3011315878 hasAuthorship W3011315878A5034549468 @default.
• W3011315878 hasAuthorship W3011315878A5051029267 @default.
• W3011315878 hasAuthorship W3011315878A5065370227 @default.
• W3011315878 hasAuthorship W3011315878A5082395003 @default.
• W3011315878 hasAuthorship W3011315878A5084707615 @default.
• W3011315878 hasConcept C126322002 @default.
• W3011315878 hasConcept C141071460 @default.
• W3011315878 hasConcept C16020263 @default.
• W3011315878 hasConcept C165637977 @default.
• W3011315878 hasConcept C167135981 @default.
• W3011315878 hasConcept C197934379 @default.
• W3011315878 hasConcept C2776694085 @default.
• W3011315878 hasConcept C2776755627 @default.
• W3011315878 hasConcept C2777543607 @default.
• W3011315878 hasConcept C2777714996 @default.
• W3011315878 hasConcept C2779017958 @default.
• W3011315878 hasConcept C2779338263 @default.
• W3011315878 hasConcept C2780653079 @default.
• W3011315878 hasConcept C3018587741 @default.
• W3011315878 hasConcept C55520419 @default.
• W3011315878 hasConcept C71924100 @default.
• W3011315878 hasConcept C90924648 @default.
• W3011315878 hasConceptScore W3011315878C126322002 @default.
• W3011315878 hasConceptScore W3011315878C141071460 @default.
• W3011315878 hasConceptScore W3011315878C16020263 @default.
• W3011315878 hasConceptScore W3011315878C165637977 @default.
• W3011315878 hasConceptScore W3011315878C167135981 @default.

• next